Precision Cancer Imaging Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	250 Pages	Future Market Insights	November, 2022	FMARI18288076

Best Price Guarantee
Price	from $5,000
Length	250 Pages
Publisher	Future Market Insights
Published Date	November, 2022
SKU	FMARI18288076

Precision Cancer Imaging Market: Global Industry Analysis 2017-2021 and Opportunity Assessment 2022-2032

A recent market study published by FMI on Precision Cancer Imaging offers a global industry analysis for 2017-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

Modality
end user
Region

Report Chapters

Executive Summary

The executive summary of the Precision Cancer Imaging Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Precision Cancer Imaging.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Precision Cancer Imaging Market in this chapter, which will help to understand basic information about Precision Cancer Imaging. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Precision Cancer Imaging Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Nature processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Precision Cancer Imaging Market Demand Analysis 2017-2021 and Forecast, 2022-2032

The chapter include historical market value (US$ XX Billion) analysis (2017-2021) and current and future market value (US$ 47225.2 Million) and volume (12%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Precision Cancer Imaging Market - Pricing Analysis

Based on By Nature, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Modality

Based on By Modality, Precision Cancer Imaging Market is segmented into. This section also offers market attractiveness analysis based on By Modality. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Modality.

Chapter 06 - Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By end user

Based on By end user, Precision Cancer Imaging Market is segmented into. This section also offers market attractiveness analysis based on By end user. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By end user.

Chapter 07 - Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Region

Based on By Region, Precision Cancer Imaging Market is segmented into North America,Latin America,Europe,East Asia,South Asia & Pacific,Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 08 - North America Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Precision Cancer Imaging in the North American Region, along with a country-wise assessment that includes the US and Canada. Readers can also find Regional trends, regulations, and market growth based on different segment and countries in the North America Region.

Chapter 09 - Latin America Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Precision Cancer Imaging in the Latin America Region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Precision Cancer Imaging Market in the Latin America Region.

Chapter 10 - Europe Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Precision Cancer Imaging in the European Region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Precision Cancer Imaging Market in the Regional market.

Chapter 11 - East Asia Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Precision Cancer Imaging in the East Asia Region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Precision Cancer Imaging Market in the Regional market.

Chapter 12 - South Asia Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Precision Cancer Imaging in the South Asia Region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Precision Cancer Imaging Market in the Regional market.

Chapter 13 - Middle East and Africa Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of Precision Cancer Imaging in the MEA Region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Precision Cancer Imaging Market in the Regional market.

Chapter 14 - Key Countries Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032

This chapter offers insights into how the Precision Cancer Imaging Market is expected to grow in major countries globally.

Chapter 15 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 16 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Nature portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are GE Healthcare (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Philips Healthcare) (Netherlands), Hitachi, Ltd. (Hitachi Medical Corporation) (Japan), Shimadzu Corporation (Japan), Toshiba Corporation (Japan), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Carestream Health (U.S.), Esaote SpA (Italy) and others.

Chapter 17 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Precision Cancer Imaging report.

Chapter 18 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Precision Cancer Imaging Market.

1. Executive Summary: 1.1. Global Market Outlook; 1.2. Demand-side Trends; 1.3. Supply-side Trends; 1.4. Technology Roadmap Analysis; 1.5. Analysis and Recommendations
2. Market Overview: 2.1. Market Coverage / Taxonomy; 2.2. Market Definition / Scope / Limitations
3. Market Background: 3.1. Market Dynamics; 3.1.1. Drivers; 3.1.2. Restraints; 3.1.3. Opportunity; 3.1.4. Trends; 3.2. Scenario Forecast; 3.2.1. Demand in Optimistic Scenario; 3.2.2. Demand in Likely Scenario; 3.2.3. Demand in Conservative Scenario; 3.3. Opportunity Map Analysis; 3.4. Product Life Cycle Analysis; 3.5. Supply Chain Analysis; 3.5.1. Supply Side Participants and their Roles; 3.5.1.1. Producers; 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers); 3.5.1.3. Wholesalers and Distributors; 3.5.2. Value Added and Value Created at Node in the Supply Chain; 3.5.3. List of Raw Material Suppliers; 3.5.4. List of Existing and Potential Buyer’s; 3.6. Investment Feasibility Matrix; 3.7. Value Chain Analysis; 3.7.1. Profit Margin Analysis; 3.7.2. Wholesalers and Distributors; 3.7.3. Retailers; 3.8. PESTLE and Porter’s Analysis; 3.9. Regulatory Landscape; 3.9.1. By Key Regions; 3.9.2. By Key Countries; 3.10. Regional Parent Market Outlook; 3.11. Production and Consumption Statistics; 3.12. Import and Export Statistics
4. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast, 2022-2032: 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021; 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032; 4.2.1. Y-o-Y Growth Trend Analysis; 4.2.2. Absolute $ Opportunity Analysis
5. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Imaging Technique: 5.1. Introduction / Key Findings; 5.2. Historical Market Size Value (US$ Mn) Analysis By Imaging Technique, 2017-2021; 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Imaging Technique, 2022-2032; 5.3.1. Magnetic Resonance Imaging; 5.3.2. Molecular Imaging; 5.3.3. Nuclear Medicine Scans; 5.4. Y-o-Y Growth Trend Analysis By Imaging Technique, 2017-2021; 5.5. Absolute $ Opportunity Analysis By Imaging Technique, 2022-2032; Deep-dive segmentation will be available in the sample on request
6. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By End User: 6.1. Introduction / Key Findings; 6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021; 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032; 6.3.1. Hospitals; 6.3.2. Research Laboratories; 6.3.3. Diagnostic Laboratories; 6.3.4. Academic Research Institutes; 6.3.5. Specialty Clinics; 6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021; 6.5. Absolute $ Opportunity Analysis By End User, 2022-2032; Deep-dive segmentation will be available in the sample on request
7. Global Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Region: 7.1. Introduction; 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021; 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032; 7.3.1. North America; 7.3.2. Latin America; 7.3.3. Europe; 7.3.4. East Asia; 7.3.5. South Asia & Pacific; 7.3.6. MEA; 7.4. Market Attractiveness Analysis By Region
8. North America Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021; 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032; 8.2.1. By Country; 8.2.1.1. U.S.; 8.2.1.2. Canada; 8.2.2. By Imaging Technique; 8.2.3. By End User; 8.3. Market Attractiveness Analysis; 8.3.1. By Country; 8.3.2. By Imaging Technique; 8.3.3. By End User; 8.4. Key Takeaways
9. Latin America Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021; 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032; 9.2.1. By Country; 9.2.1.1. Brazil; 9.2.1.2. Mexico; 9.2.1.3. Rest of Latin America; 9.2.2. By Imaging Technique; 9.2.3. By End User; 9.3. Market Attractiveness Analysis; 9.3.1. By Country; 9.3.2. By Imaging Technique; 9.3.3. By End User; 9.4. Key Takeaways
10. Europe Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021; 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032; 10.2.1. By Country; 10.2.1.1. Germany; 10.2.1.2. U.K.; 10.2.1.3. France; 10.2.1.4. Spain; 10.2.1.5. Italy; 10.2.1.6. Rest of Europe; 10.2.2. By Imaging Technique; 10.2.3. By End User; 10.3. Market Attractiveness Analysis; 10.3.1. By Country; 10.3.2. By Imaging Technique; 10.3.3. By End User; 10.4. Key Takeaways
11. East Asia Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021; 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032; 11.2.1. By Country; 11.2.1.1. China; 11.2.1.2. Japan; 11.2.1.3. South Korea; 11.2.2. By Imaging Technique; 11.2.3. By End User; 11.3. Market Attractiveness Analysis; 11.3.1. By Country; 11.3.2. By Imaging Technique; 11.3.3. By End User; 11.4. Key Takeaways
12. South Asia & Pacific Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021; 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032; 12.2.1. By Country; 12.2.1.1. India; 12.2.1.2. Thailand; 12.2.1.3. Indonesia; 12.2.1.4. Malaysia; 12.2.1.5. Singapore; 12.2.1.6. Australia; 12.2.1.7. New Zealand; 12.2.1.8. Rest of South Asia & Pacific; 12.2.2. By Imaging Technique; 12.2.3. By End User; 12.3. Market Attractiveness Analysis; 12.3.1. By Country; 12.3.2. By Imaging Technique; 12.3.3. By End User; 12.4. Key Takeaways
13. MEA Precision Cancer Imaging Market Analysis 2017-2021 and Forecast 2022-2032, By Country: 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021; 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032; 13.2.1. By Country; 13.2.1.1. GCC Countries; 13.2.1.2. South Africa; 13.2.1.3. Israel; 13.2.1.4. Rest of MEA; 13.2.2. By Imaging Technique; 13.2.3. By End User; 13.3. Market Attractiveness Analysis; 13.3.1. By Country; 13.3.2. By Imaging Technique; 13.3.3. By End User; 13.4. Key Takeaways
14. Key Countries Precision Cancer Imaging Market Analysis: 14.1. U.S.; 14.1.1. Pricing Analysis; 14.1.2. Market Share Analysis, 2021; 14.1.2.1. By Imaging Technique; 14.1.2.2. By End User; 14.2. Canada; 14.2.1. Pricing Analysis; 14.2.2. Market Share Analysis, 2021; 14.2.2.1. By Imaging Technique; 14.2.2.2. By End User; 14.3. Brazil; 14.3.1. Pricing Analysis; 14.3.2. Market Share Analysis, 2021; 14.3.2.1. By Imaging Technique; 14.3.2.2. By End User; 14.4. Mexico; 14.4.1. Pricing Analysis; 14.4.2. Market Share Analysis, 2021; 14.4.2.1. By Imaging Technique; 14.4.2.2. By End User; 14.5. Germany; 14.5.1. Pricing Analysis; 14.5.2. Market Share Analysis, 2021; 14.5.2.1. By Imaging Technique; 14.5.2.2. By End User; 14.6. U.K.; 14.6.1. Pricing Analysis; 14.6.2. Market Share Analysis, 2021; 14.6.2.1. By Imaging Technique; 14.6.2.2. By End User; 14.7. France; 14.7.1. Pricing Analysis; 14.7.2. Market Share Analysis, 2021; 14.7.2.1. By Imaging Technique; 14.7.2.2. By End User; 14.8. Spain; 14.8.1. Pricing Analysis; 14.8.2. Market Share Analysis, 2021; 14.8.2.1. By Imaging Technique; 14.8.2.2. By End User; 14.9. Italy; 14.9.1. Pricing Analysis; 14.9.2. Market Share Analysis, 2021; 14.9.2.1. By Imaging Technique; 14.9.2.2. By End User; 14.10. China; 14.10.1. Pricing Analysis; 14.10.2. Market Share Analysis, 2021; 14.10.2.1. By Imaging Technique; 14.10.2.2. By End User; 14.11. Japan; 14.11.1. Pricing Analysis; 14.11.2. Market Share Analysis, 2021; 14.11.2.1. By Imaging Technique; 14.11.2.2. By End User; 14.12. South Korea; 14.12.1. Pricing Analysis; 14.12.2. Market Share Analysis, 2021; 14.12.2.1. By Imaging Technique; 14.12.2.2. By End User; 14.13. India; 14.13.1. Pricing Analysis; 14.13.2. Market Share Analysis, 2021; 14.13.2.1. By Imaging Technique; 14.13.2.2. By End User; 14.14. Thailand; 14.14.1. Pricing Analysis; 14.14.2. Market Share Analysis, 2021; 14.14.2.1. By Imaging Technique; 14.14.2.2. By End User; 14.15. Indonesia; 14.15.1. Pricing Analysis; 14.15.2. Market Share Analysis, 2021; 14.15.2.1. By Imaging Technique; 14.15.2.2. By End User; 14.16. Malaysia; 14.16.1. Pricing Analysis; 14.16.2. Market Share Analysis, 2021; 14.16.2.1. By Imaging Technique; 14.16.2.2. By End User; 14.17. Singapore; 14.17.1. Pricing Analysis; 14.17.2. Market Share Analysis, 2021; 14.17.2.1. By Imaging Technique; 14.17.2.2. By End User; 14.18. Australia; 14.18.1. Pricing Analysis; 14.18.2. Market Share Analysis, 2021; 14.18.2.1. By Imaging Technique; 14.18.2.2. By End User; 14.19. New Zealand; 14.19.1. Pricing Analysis; 14.19.2. Market Share Analysis, 2021; 14.19.2.1. By Imaging Technique; 14.19.2.2. By End User; 14.20. GCC Countries; 14.20.1. Pricing Analysis; 14.20.2. Market Share Analysis, 2021; 14.20.2.1. By Imaging Technique; 14.20.2.2. By End User; 14.21. South Africa; 14.21.1. Pricing Analysis; 14.21.2. Market Share Analysis, 2021; 14.21.2.1. By Imaging Technique; 14.21.2.2. By End User; 14.22. Israel; 14.22.1. Pricing Analysis; 14.22.2. Market Share Analysis, 2021; 14.22.2.1. By Imaging Technique; 14.22.2.2. By End User
15. Market Structure Analysis: 15.1. Competition Dashboard; 15.2. Competition Benchmarking; 15.3. Market Share Analysis of Top Players; 15.3.1. By Regional; 15.3.2. By Imaging Technique; 15.3.3. By End User
16. Competition Analysis: 16.1. Competition Deep Dive; 16.1.1. General Electric Company; 16.1.1.1. Overview; 16.1.1.2. Product Portfolio; 16.1.1.3. Profitability by Market Segments; 16.1.1.4. Sales Footprint; 16.1.1.5. Strategy Overview; 16.1.1.5.1. Marketing Strategy; 16.1.1.5.2. Product Strategy; 16.1.1.5.3. Channel Strategy; 16.1.2. Koninklijke Philips N.V.; 16.1.2.1. Overview; 16.1.2.2. Product Portfolio; 16.1.2.3. Profitability by Market Segments; 16.1.2.4. Sales Footprint; 16.1.2.5. Strategy Overview; 16.1.2.5.1. Marketing Strategy; 16.1.2.5.2. Product Strategy; 16.1.2.5.3. Channel Strategy; 16.1.3. Siemens AG; 16.1.3.1. Overview; 16.1.3.2. Product Portfolio; 16.1.3.3. Profitability by Market Segments; 16.1.3.4. Sales Footprint; 16.1.3.5. Strategy Overview; 16.1.3.5.1. Marketing Strategy; 16.1.3.5.2. Product Strategy; 16.1.3.5.3. Channel Strategy; 16.1.4. Hologic, Inc.; 16.1.4.1. Overview; 16.1.4.2. Product Portfolio; 16.1.4.3. Profitability by Market Segments; 16.1.4.4. Sales Footprint; 16.1.4.5. Strategy Overview; 16.1.4.5.1. Marketing Strategy; 16.1.4.5.2. Product Strategy; 16.1.4.5.3. Channel Strategy; 16.1.5. Hitachi, Ltd.; 16.1.5.1. Overview; 16.1.5.2. Product Portfolio; 16.1.5.3. Profitability by Market Segments; 16.1.5.4. Sales Footprint; 16.1.5.5. Strategy Overview; 16.1.5.5.1. Marketing Strategy; 16.1.5.5.2. Product Strategy; 16.1.5.5.3. Channel Strategy; 16.1.6. Shimadzu Corporation; 16.1.6.1. Overview; 16.1.6.2. Product Portfolio; 16.1.6.3. Profitability by Market Segments; 16.1.6.4. Sales Footprint; 16.1.6.5. Strategy Overview; 16.1.6.5.1. Marketing Strategy; 16.1.6.5.2. Product Strategy; 16.1.6.5.3. Channel Strategy; 16.1.7. ESAOTE SPA; 16.1.7.1. Overview; 16.1.7.2. Product Portfolio; 16.1.7.3. Profitability by Market Segments; 16.1.7.4. Sales Footprint; 16.1.7.5. Strategy Overview; 16.1.7.5.1. Marketing Strategy; 16.1.7.5.2. Product Strategy; 16.1.7.5.3. Channel Strategy; 16.1.8. Fujifilm Holdings Corporation; 16.1.8.1. Overview; 16.1.8.2. Product Portfolio; 16.1.8.3. Profitability by Market Segments; 16.1.8.4. Sales Footprint; 16.1.8.5. Strategy Overview; 16.1.8.5.1. Marketing Strategy; 16.1.8.5.2. Product Strategy; 16.1.8.5.3. Channel Strategy; 16.1.9. Carestream Health; 16.1.9.1. Overview; 16.1.9.2. Product Portfolio; 16.1.9.3. Profitability by Market Segments; 16.1.9.4. Sales Footprint; 16.1.9.5. Strategy Overview; 16.1.9.5.1. Marketing Strategy; 16.1.9.5.2. Product Strategy; 16.1.9.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology